Review
Gene Therapy (2009) 16, 3–9; doi:10.1038/gt.2008.166; published online 13 November 2008
Progress & Prospects: Gene therapy in aging
- 1Laboratory of Cellular Ageing, Department of Molecular Biology, University of Aarhus, Aarhus, Denmark
- 2FCMB ApS, Vejle, Denmark
Correspondence: Dr S Rattan, Laboratory of Cellular Ageing, Department of Molecular Biology, University of Aarhus, Gustav Wiedsvej 10C; DK8000 Aarhus – C, Denmark. E-mail: rattan@mb.au.dk
Received 8 September 2008; Revised 22 October 2008; Accepted 22 October 2008; Published online 13 November 2008.
Abstract
Studies performed on various experimental model systems indicate that genetic interventions can increase longevity, even if in a highly protected laboratory condition. Generally, such interventions required partial or complete switching off of the gene and inhibiting the activity of its gene products, which normally have other well-defined roles in metabolic processes. Overexpression of some genes, such as stress response and antioxidant genes, in some model systems also extends their longevity. Such genetic interventions may not be easily applicable to humans without knowing their effects on human growth, development, maturation, reproduction and other characteristics. Studies on the association of single nucleotide polymorphisms and multiple polymorphisms (haplotype) in genes with human longevity have identified several genes whose frequencies increase or decrease with age. Whether genetic redesigning can be achieved in the wake of numerous and complex epigenetic factors that effectively determine the life course and the life span of an individual still appears to be a 'mission impossible'.
Keywords:
antiaging, gerontogenes, longevity, homeostasis, homeodynamics
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Endocrine regulation of ageing
Nature Reviews Molecular Cell Biology Review (01 Sep 2007)
Forkhead transcription factors and ageing
Oncogene Review
Turning anti-ageing genes against cancer
Nature Reviews Molecular Cell Biology Perspective (01 Nov 2008)
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
